The Food and Drug Administration has approved a new generic version of the abortion pill mifepristone, prompting an outcry from conservatives who’ve been eager to restrict access to the medication.
The generic pill was approved in September, according to Evita Solutions, its manufacturer. It joins another generic pill that’s already on the market from GenBioPro, which was approved in 2019.
Andrew Dixon, a spokesperson for the Health and Human Services Department, noted that the FDA “has very limited discretion in deciding whether to approve a generic dMore...rug. By law, the Secretary of Health and Human Services must approve an application if it demonstrates that the generic drug is idMore...entical to the brand-name drug.”
With subsidies for Affordable Care Act (ACA) health insurance set to expire, Americans who rely on...
Connecticut, Georgia, Idaho, Massachusetts, Michigan, Rhode Island, South Carolina, Texas and Puerto Rico also saw an...
A California jury on Friday awarded $40m to two women who said Johnson & Johnson’s baby...
